Bailard’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.24M | Buy |
51,454
+8,700
| +20% | +$228K | 0.03% | 314 |
|
|
2026
Q1 | $1.2M | Sell |
42,754
-606
| -1% | -$16.1K | 0.03% | 298 |
|
|
2025
Q4 | $1.08M | Sell |
43,360
-10,713
| -20% | -$270K | 0.02% | 311 |
|
|
2025
Q3 | $1.38M | Sell |
54,073
-1,160
| -2% | -$28.6K | 0.03% | 286 |
|
|
2025
Q2 | $1.34M | Buy |
55,233
+19
| +0% | +$443 | 0.03% | 287 |
|
|
2025
Q1 | $1.4M | Buy |
55,214
+1,840
| +3% | +$48.1K | 0.04% | 262 |
|
|
2024
Q4 | $1.42M | Sell |
53,374
-1,291
| -2% | -$35K | 0.04% | 258 |
|
|
2024
Q3 | $1.58M | Sell |
54,665
-2,252
| -4% | -$65.7K | 0.04% | 251 |
|
|
2024
Q2 | $1.59M | Sell |
56,917
-162,117
| -74% | -$4.46M | 0.04% | 250 |
|
|
2024
Q1 | $6.08M | Buy |
219,034
+1,839
| +0.8% | +$51K | 0.17% | 125 |
|
|
2023
Q4 | $6.25M | Sell |
217,195
-4,219
| -2% | -$128K | 0.19% | 119 |
|
|
2023
Q3 | $7.34M | Buy |
221,414
+3,525
| +2% | +$125K | 0.24% | 90 |
|
|
2023
Q2 | $7.99M | Sell |
217,889
-3,653
| -2% | -$142K | 0.28% | 79 |
|
|
2023
Q1 | $9.04M | Sell |
221,542
-10,761
| -5% | -$465K | 0.32% | 74 |
|
|
2022
Q4 | $11.9M | Buy |
232,303
+27,714
| +14% | +$1.33M | 0.45% | 49 |
|
|
2022
Q3 | $8.95M | Sell |
204,589
-1,023
| -0.5% | -$49.7K | 0.37% | 58 |
|
|
2022
Q2 | $10.8M | Buy |
205,612
+16,960
| +9% | +$864K | 0.42% | 53 |
|
|
2022
Q1 | $9.77M | Buy |
188,652
+709
| +0.4% | +$36.8K | 0.33% | 67 |
|
|
2021
Q4 | $11.1M | Sell |
187,943
-1,241
| -0.7% | -$61.5K | 0.35% | 63 |
|
|
2021
Q3 | $8.14M | Sell |
189,184
-4
| -0% | -$177 | 0.28% | 86 |
|
|
2021
Q2 | $7.41M | Buy |
189,188
+4,981
| +3% | +$194K | 0.26% | 93 |
|
|
2021
Q1 | $6.67M | Buy |
184,207
+126,743
| +221% | +$4.5M | 0.25% | 91 |
|
|
2020
Q4 | $2.12M | Sell |
57,464
-767
| -1% | -$28.1K | 0.1% | 155 |
|
|
2020
Q3 | $2.03M | Sell |
58,231
-10,340
| -15% | -$363K | 0.11% | 146 |
|
|
2020
Q2 | $2.13M | Buy |
68,571
+38,959
| +132% | +$1.32M | 0.12% | 138 |
|
|
2020
Q1 | $917K | Sell |
29,612
-8,488
| -22% | -$289K | 0.07% | 175 |
|
|
2019
Q4 | $1.42M | Buy |
38,100
+5,671
| +17% | +$202K | 0.08% | 174 |
|
|
2019
Q3 | $1.1M | Sell |
32,429
-1,487
| -4% | -$54.1K | 0.07% | 198 |
|
|
2019
Q2 | $1.39M | Buy |
33,916
+610
| +2% | +$24.2K | 0.09% | 195 |
|
|
2019
Q1 | $1.34M | Sell |
33,306
-314
| -0.9% | -$12.6K | 0.08% | 201 |
|
|
2018
Q4 | $1.39M | Buy |
33,620
+5,641
| +20% | +$234K | 0.09% | 177 |
|
|
2018
Q3 | $1.17M | Buy |
27,979
+139
| +0.5% | +$5.35K | 0.07% | 200 |
|
|
2018
Q2 | $958K | Buy |
27,840
+3,098
| +13% | +$106K | 0.06% | 226 |
|
|
2018
Q1 | $833K | Sell |
24,742
-1,600
| -6% | -$55K | 0.05% | 238 |
|
|
2017
Q4 | $905K | Sell |
26,342
-1,701
| -6% | -$58K | 0.06% | 244 |
|
|
2017
Q3 | $950K | Buy |
28,043
+2,767
| +11% | +$88.9K | 0.07% | 167 |
|
|
2017
Q2 | $806K | Sell |
25,276
-787
| -3% | -$24.8K | 0.07% | 182 |
|
|
2017
Q1 | $846K | Sell |
26,063
-389
| -1% | -$12.3K | 0.07% | 181 |
|
|
2016
Q4 | $815K | Buy |
26,452
+1,614
| +6% | +$49.3K | 0.08% | 175 |
|
|
2016
Q3 | $798K | Sell |
24,838
-366
| -1% | -$12.2K | 0.07% | 177 |
|
|
2016
Q2 | $842K | Buy |
25,204
+11,373
| +82% | +$363K | 0.1% | 166 |
|
|
2016
Q1 | $389K | Buy |
+13,831
| New | +$395K | 0.05% | 169 |
|
|
2015
Q4 | – | Sell |
-13,616
| Closed | -$406K | – | 300 |
|
|
2015
Q3 | $406K | Buy |
13,616
+1,001
| +8% | +$32.1K | 0.06% | 157 |
|
|
2015
Q2 | $401K | Sell |
12,615
-3,274
| -21% | -$107K | 0.06% | 168 |
|
|
2015
Q1 | $524K | Buy |
15,889
+119
| +0.8% | +$3.78K | 0.07% | 151 |
|
|
2014
Q4 | $466K | Sell |
15,770
-5,607
| -26% | -$161K | 0.07% | 156 |
|
|
2014
Q3 | $600K | Buy |
21,377
+3,394
| +19% | +$95.3K | 0.09% | 117 |
|
|
2014
Q2 | $506K | Buy |
17,983
+7,943
| +79% | +$226K | 0.08% | 128 |
|
|
2014
Q1 | $306K | Buy |
10,040
+345
| +4% | +$10.3K | 0.05% | 173 |
|
|
2013
Q4 | $282K | Sell |
9,695
-307
| -3% | -$8.94K | 0.05% | 178 |
|
|
2013
Q3 | $273K | Sell |
10,002
-3,079
| -24% | -$83.8K | 0.05% | 180 |
|
|
2013
Q2 | $348K | Buy |
+13,081
| New | +$361K | 0.06% | 145 |
|
Other funds holding PFE
Bailard's PFE Position: Q2 2026 in Review
Bailard increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $228K and bringing the position to 51,454 shares worth $1.24M. The position accounts for 0.03% of the portfolio, ranked #314.
Bailard first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9M in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bailard held 51,454 shares of Pfizer worth $1.24M as of Q2 2026.
- Bailard bought 8,700 Pfizer shares in Q2 2026, an estimated $228K.
- Pfizer made up 0.03% of Bailard's portfolio in Q2 2026, its #314 holding.
- Bailard first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bailard's Pfizer position peaked at $11.9M in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.